Amilton Mouro

Amilton Mouro

Auto-generated profile, based on publicly available information

Amilton Mouro

Lab San Matre, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
FSFarid Samaan
Farid Samaan
RSRubens Carvalho Silveira
Rubens Carvalho Silveira
AMAmilton Mouro
Amilton Mouro
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
RSRicardo de Castro Cintra Sesso
Ricardo de Castro Cintra Sesso
Although approximately 25% of Brazilians have private health coverage (PHC), studies on the surveillance of chronic kidney disease (CKD) in this population are scarce. The objective of this study was to estimate the prevalence of CKD in individuals under two PHC regimes in Brazil, who total 8,335,724 beneficiaries. Outpatient serum creatinine and proteinuria results of individuals from all five regions of Brazil, ≥ 18 years of age, and performed between 10/01/2021 and 10/31/2022, were analyzed through the own laboratory network database. People with serum creatinine measurements were evaluated for the prevalence and staging of CKD, and those with simultaneous measurements of serum creatinine and proteinuria were evaluated for the risk category of the disease. CKD was classified according to current guidelines and was defined as a glomerular filtration rate (GFR) < 60 ml/min/1.73 m² estimated by the 2021 CKD-EPI equation. The number of adults with serum creatinine results was 1,508,766 (age 44.0 [IQR, 33.9–56.8] years, 62.3% female). The estimated prevalence of CKD was 3.8% (2.6%, 0.8%, 0.2% and 0.2% in CKD stages 3a, 3b, 4 and 5, respectively), and it was higher in males than females (4.0% vs. 3.7%, p < 0.001, respectively) and in older age groups (0.2% among 18-29-year-olds, 0.5% among 30-44-year-olds, 2.0% among 45-59-year-olds, 9.4% among 60-74-year-olds, and 32.4% among ≥ 75-year-olds, p < 0.001) Adults with simultaneous results of creatinine and proteinuria were 64,178 (age 57.0 [IQR, 44.8–67.3] years, 58.1% female). After adjusting for age and gender, 70.1% were in the low-risk category of CKD, 20.0% were in the moderate-risk category, 5.8% were in the high-risk category, and 4.1% were in the very high-risk category. The estimated prevalence of CKD was 3.8%, and approximately 10% of the participants were in the categories of high or very high-risk of the disease. While almost 20% of beneficiaries with PHC had serum creatinine data, fewer than 1% underwent tests for proteinuria. This study was one of the largest ever conducted in Brazil and the first one to use the 2021 CKD-EPI equation to estimate the prevalence of CKD.

3 September 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
FSFarid Samaan
Farid Samaan
CVCristiane Akemi Vicente
Cristiane Akemi Vicente
AMAmilton Mouro
Amilton Mouro
VBVitória Ângela Lorenzini Bellotto Bellini
Vitória Ângela Lorenzini Bellotto Bellini
RSRenata Santos
Renata Santos
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
The objectives of this study were to compare the sensitivity of two urine dipstick tests commercially available for detecting proteinuria and to project th